The gene encoding the cytoskeleton modulator DIAPH3 is lost frequently in metastatic prostate cancer, and DIAPH3 silencing induces a shift to an amoeba-like tumor phenotype in a variety of cellular settings. Here, DIAPH3 is linked to metastatic prostate carcinoma.